ERBB2 and breast carcinoma: The association with tumor grade has been shown for several multigene assays [48–51] and tumor grade has also been incorporated in prognostic index (Nottingham Px) for prognostic stratification of the clinically intermediate-risk group of breast cancer (node negative ER-positive/HER2-negative) [52].